Gene · 2798
Papers2,995
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,995
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Precocious Puberty: Types, Pathogenesis and Updated Management. | Cureus | 2023 | 38021712 | PubTator, text mining | PubMed |
| A Critical Analysis of the FDA's Omics-Driven Pharmacodynamic Biomarkers to Establish Biosimilarity. | Pharmaceuticals (Basel) | 2023 | 38004421 | PubTator, text mining | PubMed |
| The FDA's New Guideline "Generally Accepted Scientific Knowledge" (GASK): An Opportunity to Expedite the Approval of Biosimilars. | Pharmaceuticals (Basel) | 2023 | 38004383 | PubTator, text mining | PubMed |
| Use of the Subcutaneous Triptorelin Stimulation Test for Diagnosis of Central Precocious Puberty. | Children (Basel) | 2023 | 38002921 | PubTator, text mining | PubMed |
| Increased Serum Levels of Phoenixin-14, Nesfatin-1 and Dopamine Are Associated with Positive Pregnancy Rate after Ovarian Stimulation. | J Clin Med | 2023 | 38002606 | PubTator, text mining | PubMed |
| [Hormonal and genetic causes of cryptorchidism]. | Probl Endokrinol (Mosk) | 2023 | 37968957 | PubTator, text mining | PubMed |
| Combined Therapy with Anthracyclines and GnRH Analogues for Breast Cancer: Impact on Ischemic Heart Disease. | J Clin Med | 2023 | 37959257 | PubTator, text mining | PubMed |
| Diminished Ovarian Reserve in Endometriosis: Insights from In Vitro, In Vivo, and Human Studies-A Systematic Review. | Int J Mol Sci | 2023 | 37958954 | PubTator, text mining | PubMed |
| Gonadotropin-Releasing Hormone Receptor (GnRHR) and Hypogonadotropic Hypogonadism. | Int J Mol Sci | 2023 | 37958948 | PubTator, text mining | PubMed |
| TOLLIP acts as a cargo adaptor to promote lysosomal degradation of aberrant ER membrane proteins. | EMBO J | 2023 | 37929762 | PubTator, text mining | PubMed |
| Proteomic profiling of urinary extracellular vesicles differentiates breast cancer patients from healthy women. | PLoS One | 2023 | 37922300 | PubTator, text mining | PubMed |
| Early biochemical outcomes following neoadjuvant/adjuvant relugolix with stereotactic body radiation therapy for intermediate to high risk prostate cancer. | Front Oncol | 2023 | 37916156 | PubTator, text mining | PubMed |
| MIR938 rs2505901 T>C polymorphism is associated with increased neuroblastoma risk in Chinese children. | Biosci Rep | 2023 | 37905791 | PubTator, text mining | PubMed |
| Apalutamide-Induced Toxic Epidermal Necrolysis in a Caucasian Patient with Metastatic Castration-Sensitive Prostate Cancer: A Case Report and Review of the Literature. | Case Rep Oncol | 2023 | 37900799 | PubTator, text mining | PubMed |
| Overactivation of GnRH neurons is sufficient to trigger polycystic ovary syndrome-like traits in female mice. | EBioMedicine | 2023 | 37898094 | PubTator, text mining | PubMed |
| Radiometals in Imaging and Therapy: Highlighting Two Decades of Research. | Pharmaceuticals (Basel) | 2023 | 37895931 | PubTator, text mining | PubMed |
| RETRACTED: EGF-Enhanced GnRH-II Regulation in Decidual Stromal Cell Motility through Twist and N-Cadherin Signaling. | Int J Mol Sci | 2023 | 37894950 | PubTator, text mining | PubMed |
Rational Design, Synthesis and Binding Affinity Studies of Anthraquinone Derivatives Conjugated to Gonadotropin-Releasing Hormone (GnRH) Analogues towards Selective Immunosuppression of Hormone-Dependent Cancer. | Int J Mol Sci | 2023 | 37894912 | PubTator, text mining | PubMed |
| Clinical Management and Therapy of Precocious Puberty in the Sapienza University Pediatrics Hospital of Rome, Italy. | Children (Basel) | 2023 | 37892335 | PubTator, text mining | PubMed |
| The G Protein-Coupled Estrogen Receptor (GPER): A Critical Therapeutic Target for Cancer. | Cells | 2023 | 37887304 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2798/papers?page=8